{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:06:08Z","timestamp":1767708368160,"version":"3.48.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04626-x","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T02:26:33Z","timestamp":1764642393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal hypouricemia type 2 in a patient with latent autoimmune diabetes in adults: a case report and literature review"],"prefix":"10.1186","volume":"27","author":[{"given":"Yunyi","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"23","key":"4626_CR1","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.3390\/nu16234072","volume":"16","author":"NG Mourelatou","year":"2024","unstructured":"Mourelatou NG, Kounatidis D, Jude EB, Rebelos E. Vitamin D supplementation as a therapeutic strategy in autoimmune diabetes: insights and implications for lada management. Nutrients. 2024, Nov, 27;16(23):4072. https:\/\/doi.org\/10.3390\/nu16234072. PMID: 39683465; PMCID: PMC11643312.","journal-title":"Nutrients"},{"key":"4626_CR2","doi-asserted-by":"publisher","first-page":"503828","DOI":"10.1016\/j.mrgentox.2024.503828","volume":"900","author":"G Parsadanyan","year":"2024","unstructured":"Parsadanyan G, Zalinyan G, Markosyan R, Sarkisyan M, Aghajanova E, Sahakyan A. Investigation of genetic instability in patients with diabetes mellitus type I, II and LADA using buccal micronucleus cytome assay. Mutat Res Genet Toxicol Environ Mutagen. 2024, Nov-Dec;900:503828. https:\/\/doi.org\/10.1016\/j.mrgentox.2024.503828. Epub 2024 Oct 22. PMID: 39617593.","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"4626_CR3","doi-asserted-by":"publisher","first-page":"110842","DOI":"10.1016\/j.clinbiochem.2024.110842","volume":"135","author":"M Liepert","year":"2025","unstructured":"Liepert M, Alhaqqan S, Husain A, Lochnan H, Booth RA, Shaw J, Sun CJ. The potential of anti-glutamic acid decarboxylase antibodies to support a diagnosis of autoimmune diabetes mellitus. Clin Biochem. 2025, Jan;135:110842. https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110842. Epub 2024 Nov 17. PMID: 39551460.","journal-title":"Clin Biochem"},{"issue":"11","key":"4626_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrendo.2017.99","volume":"13","author":"R Buzzetti","year":"2017","unstructured":"Buzzetti R, Zampetti S, Maddaloni E. Adult-onset autoimmune diabetes: current knowledge and implications for management. Nat Rev Endocrinol. 2017, Nov;13(11):674\u201386. https:\/\/doi.org\/10.1038\/nrendo.2017.99. Epub 2017 Sep 8. PMID: 28885622.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"4626_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2337\/dc20-2834","volume":"44","author":"AG Jones","year":"2021","unstructured":"Jones AG, Tj M, Shields BM, Hagopian W, Hattersley AT. Latent autoimmune diabetes of adults (lada) is likely to represent a mixed population of autoimmune (type 1) and nonautoimmune (type 2) diabetes. Diabetes Care. 2021, Jun;44(6):1243\u201351. https:\/\/doi.org\/10.2337\/dc20-2834. Epub 2021 May 20. PMID: 34016607; PMCID: PMC8247509.","journal-title":"Diabetes Care"},{"key":"4626_CR6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf001","author":"R Amendolara","year":"2025","unstructured":"Amendolara R, D\u2019Onofrio L, Sessa RL, Di Giulio S, Mignogna C, Coraggio L, Schirano R, Zampetti S, Malandrucco I, Pozzilli P, Giannini G, Maddaloni E, Buzzetti R. IFN-\u03b1 neutralizing antibodies distinguish lada from early-onset type 1 diabetes. J Clin Endocrinol Metab. 2025, Jan, 6. https:\/\/doi.org\/10.1210\/clinem\/dgaf001. dgaf001. Epub ahead of print. PMID: 39760686.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4626_CR7","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2337\/dbi20-0017","volume":"69","author":"R Buzzetti","year":"2020","unstructured":"Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes. 2020, Oct;69(10):2037\u201347. https:\/\/doi.org\/10.2337\/dbi20-0017. Epub 2020 Aug 26. PMID: 32847960; PMCID: PMC7809717.","journal-title":"Diabetes"},{"key":"4626_CR8","doi-asserted-by":"publisher","unstructured":"Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Beck-Neilsen H, Tuomilehto J, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum WA, Williams R, Brophy S, Pozzilli P, Leslie RD, Consortium AL. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action lada 7. Diabetes Care. 2013. Apr;36(4):908\u201313). https:\/\/doi.org\/10.2337\/dc12-0931. Epub 2012 Dec 17.Erratum in: Diabetes Care. 2014 May;37(5):1494. PMID: 23248199; PMCID: PMC3609504.","DOI":"10.2337\/dc12-0931"},{"issue":"2","key":"4626_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3803\/EnM.2018.33.2.147","volume":"33","author":"P Pozzilli","year":"2018","unstructured":"Pozzilli P, Pieralice S. Latent autoimmune diabetes in adults: current status and new horizons. Endocrinol Metab (seoul). 2018, Jun;33(2):147\u201359. https:\/\/doi.org\/10.3803\/EnM.2018.33.2.147. PMID: 29947172; PMCID: PMC6021307.","journal-title":"Endocrinol Metab (seoul)"},{"issue":"1","key":"4626_CR10","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.2337\/dc13-1523","volume":"37","author":"OE Johansen","year":"2014","unstructured":"Johansen OE, Boehm BO, Grill V, Torjesen PA, Bhattacharya S, Patel S, Wetzel K, Woerle HJ. C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study. Diabetes Care. 2014;37(1):e11\u20132. https:\/\/doi.org\/10.2337\/dc13-1523. PMID: 24356601.","journal-title":"Diabetes Care"},{"issue":"12","key":"4626_CR11","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.2337\/dc18-1087","volume":"41","author":"P Dandona","year":"2018","unstructured":"Dandona P, Mathieu C, Phillip M, Hansen L, Tsch\u00f6pe D, Thor\u00e9n F, Xu J, Langkilde AM. DEPICT-1 investigators. Efficacy and safety of Dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study. Diabetes Care. 2018, Dec;41(12):2552\u201359. https:\/\/doi.org\/10.2337\/dc18-1087. Epub 2018 Oct 23. PMID: 30352894.","journal-title":"Diabetes Care"},{"issue":"24","key":"4626_CR12","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1056\/NEJMoa1708337","volume":"377","author":"SK Garg","year":"2017","unstructured":"Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D, Lapuerta P, Sim\u00f3 R, Danne T, Dk M, Kushner JA, Peters A, Strumph P. Effects of sotagliflozin added to Insulin in patients with type 1 diabetes. N Engl J Med. 2017, Dec, 14;377(24):2337\u201348. https:\/\/doi.org\/10.1056\/NEJMoa1708337. Epub 2017 Sep 13. PMID: 28899222.","journal-title":"N Engl J Med"},{"issue":"6","key":"4626_CR13","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/dom.13237","volume":"20","author":"P Pozzilli","year":"2018","unstructured":"Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J, Martin S, Schloot NC. Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (lada): a post-hoc analysis of the AWARD-2, -4 and -5 trials. Diabetes Obes Metab. 2018, Jun;20(6):1490\u201398. https:\/\/doi.org\/10.1111\/dom.13237. Epub 2018 Feb 21. PMID: 29377522.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"4626_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/dmrr.2717","volume":"32","author":"R Buzzetti","year":"2016","unstructured":"Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B. Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (lada). Diabetes Metab Res Rev. 2016, Mar;32(3):289\u201396. https:\/\/doi.org\/10.1002\/dmrr.2717. Epub 2015 Oct 28. PMID: 26385269.","journal-title":"Diabetes Metab Res Rev"},{"key":"4626_CR15","doi-asserted-by":"publisher","first-page":"1463913","DOI":"10.3389\/fneph.2024.1463913","volume":"4","author":"NR Paladugu","year":"2024","unstructured":"Paladugu NR, Vukkadala M. Renal hypouricemia type 2 with SLC2A9 compound heterozygous variants: a case report of recurrent acute kidney injury triggered by low-intensity exercise. Front Nephrol. 2024, Oct, 3;4:1463913. https:\/\/doi.org\/10.3389\/fneph.2024.1463913. PMID: 39421323; PMCID: PMC11484053.","journal-title":"Front Nephrol"},{"issue":"9","key":"4626_CR16","doi-asserted-by":"publisher","first-page":"e9368","DOI":"10.1002\/ccr3.9368","volume":"12","author":"Y Sakurabu","year":"2024","unstructured":"Sakurabu Y, Uchida HA, Tahara T, Asakawa T, Yamasaki H, Katayama K, Okamoto S, Onishi Y, Matsuoka-Uchiyama N, Tanaka K, Takeuchi H, Tsuji K, Umebayashi R, Ohashi Y, Ichida K, Wada J. A case of renal hypouricemia due to T217M mutation in SLC22A12 incidentally associated with IgA nephropathy. Clin Case Rep. 2024, Aug, 27;12(9):e9368. https:\/\/doi.org\/10.1002\/ccr3.9368. PMID: 39206069; PMCID: PMC11349819.","journal-title":"Clin Case Rep"},{"issue":"2","key":"4626_CR17","doi-asserted-by":"publisher","first-page":"2373271","DOI":"10.1080\/0886022X.2024.2373271","volume":"46","author":"Y Gao","year":"2024","unstructured":"Gao Y, Xu L, Wei M, Qu X, Pan T, Li X. Unmasking the silent culprit: recurrent exercise-induced acute kidney injury in a Chinese adolescent with renal hypouricemia. Ren Fail. 2024, Dec;46(2):2373271. https:\/\/doi.org\/10.1080\/0886022X.2024.2373271. Epub 2024 Aug 6. PMID: 39107999; PMCID: PMC11308975.","journal-title":"Ren Fail"},{"key":"4626_CR18","doi-asserted-by":"publisher","first-page":"1218232","DOI":"10.3389\/fmed.2024.1218232","volume":"11","author":"Y Yang","year":"2024","unstructured":"Yang Y, Mu X, Wu Z, An Z, Li S. Renal hypouricemia complicated with kidney stone: a case report. Front Med (Lausanne). 2024, Feb, 7;11:1218232. https:\/\/doi.org\/10.3389\/fmed.2024.1218232. PMID: 38384421; PMCID: PMC10878990.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"4626_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jccase.2023.10.009","volume":"29","author":"G Izumi","year":"2023","unstructured":"Izumi G, Takeda A, Okamoto T, Shida S, Matsuo H. A case of tachycardia-induced acute kidney injury by renal hypouricemia. J Cardiol Cases. 2023, Nov, 10;29(2):59\u201362. https:\/\/doi.org\/10.1016\/j.jccase.2023.10.009. PMID: 38362583; PMCID: PMC10865112.","journal-title":"J Cardiol Cases"},{"issue":"1","key":"4626_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40291-023-00683-w","volume":"28","author":"L Mou","year":"2024","unstructured":"Mou L, Zhu L, Chen X, Hu Y, Zhu H, Xu Y. Genotype and phenotype of renal hypouricemia: a single-center study from China. Mol Diagn Ther. 2024, Jan;28(1):87\u201399. https:\/\/doi.org\/10.1007\/s40291-023-00683-w. Epub 2023 Nov 16. PMID: 37971623.","journal-title":"Mol Diagn Ther"},{"key":"4626_CR21","doi-asserted-by":"publisher","unstructured":"Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T, Hosoyamada M, Yamaguchi S, Hisatome I, Ichida K, Shinomiya N. Clinical practice guideline for renal hypouricemia (1st edition). Hum Cell. 2019, Apr;32(2):83\u201387. https:\/\/doi.org\/10.1007\/s13577-019-00239-3. Epub 2019 Feb 19. PMID: 30783949; PMCID: PMC6437292.","DOI":"10.1007\/s13577-019-00239-3"},{"issue":"2","key":"4626_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10157-024-02558-8","volume":"29","author":"S Sugihara","year":"2025","unstructured":"Sugihara S, Yamamoto Y, Teramoto K, Hamada T, Miyazaki S, Ogino K, Kuwabara M, Ohtahara A, Mizuta E, Ichida K, Endo Y, Minato H, Ninomiya H, Kato M, Yamamoto K, Hisatome I. Annual change in eGFR in renal hypouricemia: a retrospective pilot study. Clin Exp Nephrol. 2025, Feb;29(2):173\u201381. https:\/\/doi.org\/10.1007\/s10157-024-02558-8. Epub 2024 Oct 3. PMID: 39361182; PMCID: PMC11828821.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"4626_CR23","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.3390\/ijms24098455","volume":"24","author":"A Perdomo-Ramirez","year":"2023","unstructured":"Perdomo-Ramirez A, Cordoba-Lanus E, Trujillo-Frias CJ, Gonzalez-Navasa C, Ramos-Trujillo E, Luis-Yanes MI, Garcia-Nieto V, Claverie-Martin F, R. Pathogenic variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish patients with renal hypouricemia: Founder effect of SLC2A9 variant c.374C>T; p.(T125M). Int J Mol Sci. 2023, May, 8;24(9):8455. https:\/\/doi.org\/10.3390\/ijms24098455. PMID: 37176161; PMCID: PMC10179447.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4626_CR24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.ekir.2024.04.040","volume":"9","author":"S Sulaiman","year":"2024","unstructured":"Sulaiman S, Balan S, Gopika KN, Hafeeq B, Ramachandran R, Aziz F, Nisha M, Narayanan R, Gopinathan J, Krishnakumar A, Rahman S. Donor-derived hereditary renal hypouricemia. Kidney Int Rep. 2024, Apr, 24;9(6):1923\u201324. https:\/\/doi.org\/10.1016\/j.ekir.2024.04.040. PMID: 38899214; PMCID: PMC11184320.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"4626_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s13577-024-01079-6","volume":"37","author":"Y Toyoda","year":"2024","unstructured":"Toyoda Y, Takada T, Nakayama A, Shinomiya N, Matsuo H. Biochemical characterization of renal hypouricemia-associated mutations in urate transporter genes using human cells. Hum Cell. 2024, Jul;37(4):1231\u201334. https:\/\/doi.org\/10.1007\/s13577-024-01079-6. Epub 2024 May 29. PMID: 38811494.","journal-title":"Hum Cell"},{"key":"4626_CR26","doi-asserted-by":"publisher","first-page":"PMID: 34412930","DOI":"10.1016\/j.nefro.2021.07.006","volume-title":"English, Spanish","author":"K Kaynar","year":"2021","unstructured":"Kaynar K, G\u00fcvercin B, M \u015e, Turan N, A\u00e7\u00edky\u00fcrek F. A novel mutation in a patient with familial renal hypouricemia type 2. In: English, Spanish. Nefrologia (Engl. Epub ahead of print; 2021 Aug 16: S0211-6995(21)00154-5p. PMID: 34412930. https:\/\/doi.org\/10.1016\/j.nefro.2021.07.006.","edition":"Nefrologia (Eng"},{"key":"4626_CR27","doi-asserted-by":"publisher","first-page":"4751099","DOI":"10.1155\/2021\/4751099","volume":"2021","author":"C Maalouli","year":"2021","unstructured":"Maalouli C, Dahan K, Devresse A, Gillion V. Mutation in the SLC2A9 gene: a new family with familial renal hypouricemia type 2. Case Rep Nephrol. 2021, Sep, 23;2021:4751099. https:\/\/doi.org\/10.1155\/2021\/4751099. PMID: 34603806; PMCID: PMC8486506.","journal-title":"Case Rep Nephrol"},{"issue":"3","key":"4626_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s40620-014-0073-0","volume":"28","author":"LJ Mou","year":"2015","unstructured":"Mou LJ, Jiang LP, Hu Y. A novel homozygous GLUT9 mutation cause recurrent exercise-induced acute renal failure and posterior reversible encephalopathy syndrome. J Nephrol. 2015, Jun;28(3):387\u201392. https:\/\/doi.org\/10.1007\/s40620-014-0073-0. Epub 2014 Mar 19. PMID: 24643436.","journal-title":"J Nephrol"},{"issue":"6","key":"4626_CR29","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.3892\/mmr.2019.10726","volume":"20","author":"C Wang","year":"2019","unstructured":"Wang C, Wang J, Liu S, Liang X, Song Y, Feng L, Zhong L, Guo X. Idiopathic renal hypouricemia: a case report and literature review. Mol Med Rep. 2019, Dec;20(6):5118\u201324. https:\/\/doi.org\/10.3892\/mmr.2019.10726. Epub 2019 Oct 4. PMID: 31638209; PMCID: PMC6854582.","journal-title":"Mol Med Rep"},{"key":"4626_CR30","doi-asserted-by":"publisher","unstructured":"Mazzierli T, Cirillo L, Palazzo V, Ravaglia F, Becherucci F. Clinical features suggesting renal hypouricemia as the cause of acute kidney injury: a case report and review of the literature. J Nephrol. 2023, Apr;Mar;36;(3):651\u201357: doi:https:\/\/doi.org\/10.1007\/s40620-022-01494-8. Epub 2022 Nov 23. Erratum in: J Nephrol. 2024, Mar;37(2):539. doi: 10.1007\/s40620-024-01891-1. PMID: 36418779; PMCID: PMC10089983.","DOI":"10.1007\/s40620-022-01494-8"},{"key":"4626_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.12771\/emj.2020.43.2.35","volume":"43","author":"CM Cho","year":"2020","unstructured":"Cho CM, Cheong HI, Lee JW. Severe acute kidney injury with familial renal hypouricemia confirmed by genotyping of SLC22A12. Ewha Med J. 2020;43:35\u201338. https:\/\/doi.org\/10.12771\/emj.2020.43.2.35.","journal-title":"Ewha Med J"},{"issue":"4","key":"4626_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s10157-015-1186-z","volume":"20","author":"A Mancikova","year":"2016","unstructured":"Mancikova A, Krylov V, Hurba O, Sebesta I, Nakamura M, Ichida K, Stiburkova B. Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2. Clin Exp Nephrol. 2016, Aug;20(4):578\u201384. https:\/\/doi.org\/10.1007\/s10157-015-1186-z. Epub 2015 Oct 24. PMID: 26500098.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"4626_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/ndt\/gfr419","volume":"27","author":"D Dinour","year":"2012","unstructured":"Dinour D, Gray NK, Ganon L, Knox AJ, Shalev H, Sela BA, Campbell S, Sawyer L, Shu X, Valsamidou E, Landau D, Wright AF, Holtzman EJ. Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2. Nephrol Dial Transpl. 2012, Mar;27(3):1035\u201341. https:\/\/doi.org\/10.1093\/ndt\/gfr419. Epub 2011 Aug 2. PMID: 21810765.","journal-title":"Nephrol Dial Transpl"},{"key":"4626_CR34","doi-asserted-by":"publisher","first-page":"1048330","DOI":"10.3389\/fgene.2022.1048330","volume":"13","author":"Y Toyoda","year":"2023","unstructured":"Toyoda Y, Cho SK, Tasic V, Pavelcov\u00e1 K, Bohat\u00e1 J, Suzuki H, David VA, Yoon J, Pallaiova A, J \u0160, Nousome D, Cachau R, Winkler CA, Takada T, B S. Identification of a dysfunctional exon-skipping splice variant in GLUT9\/SLC2A9 causal for renal hypouricemia type 2. Front Genet. 2023, Jan, 17;13:1048330. https:\/\/doi.org\/10.3389\/fgene.2022.1048330. PMID: 36733941; PMCID: PMC9887137.","journal-title":"Front Genet"},{"issue":"2","key":"4626_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00125-024-06303-4","volume":"68","author":"C Santoso","year":"2025","unstructured":"Santoso C, Wei Y, Ahlqvist E, Tuomi T, Carlsson S. Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults. Diabetologia. 2025, Feb;68(2):331\u201341. https:\/\/doi.org\/10.1007\/s00125-024-06303-4. Epub 2024 Oct 28. PMID: 39467873; PMCID: PMC11732938.","journal-title":"Diabetologia"},{"issue":"5","key":"4626_CR36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1046\/j.1365-2265.2000.00983","volume":"52","author":"G Gambelunghe","year":"2000","unstructured":"Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (oxf). 2000, May;52(5):565\u201373. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00983. x. PMID: 10792335.","journal-title":"Clin Endocrinol (oxf)"},{"key":"4626_CR37","doi-asserted-by":"publisher","unstructured":"Szepietowska B, Wawrusiewicz-Kurylonek N, Kr\u0119towski A, G\u00f3rska M, Szelachowska M. Endocrine autoimmunity in patients with latent autoimmune diabetes in adults (LADA) \u2014 association with HLA genotype. Endokrynol Pol. 2016;67(2):197\u2013201. https:\/\/doi.org\/10.5603\/EP. a2016.0017. PMID: 26884287.","DOI":"10.5603\/EP."},{"issue":"1","key":"4626_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.1365-2249.2003.02205","volume":"133","author":"P Kucera","year":"2003","unstructured":"Kucera P, Nov\u00e1kov\u00e1 D, Behanov\u00e1 M, Novak J, Tlaskalov\u00e1-Hogenov\u00e1 H, Andel M. Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (lada). Clin Exp Immunol. 2003, Jul;133(1):139\u201343. https:\/\/doi.org\/10.1046\/j.1365-2249.2003.02205. x. PMID: 12823288; PMCID: PMC1808742.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"4626_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF01892900","volume":"67","author":"CM Erley","year":"1989","unstructured":"Erley CM, Hirschberg RR, Hoefer W, Schaefer K. Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia. Klin Wochenschr. 1989, Mar, 1;67(5):308\u201312. https:\/\/doi.org\/10.1007\/BF01892900. PMID: 2709741.","journal-title":"Klin Wochenschr"},{"issue":"8","key":"4626_CR40","first-page":"923","volume":"32","author":"I Ishikawa","year":"1990","unstructured":"Ishikawa I, Sakurai Y, Masuzaki S, Sugishita N, Shinoda A, Shikura N. Exercise-induced acute renal failure in 3 patients with renal hypouricemia. Nihon Jinzo Gakkai Shi. 1990, Aug;32(8):923\u201328. PMID: 2250410.","journal-title":"Nihon Jinzo Gakkai Shi"},{"issue":"6","key":"4626_CR41","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/ndt\/gfh094","volume":"19","author":"T Ohta","year":"2004","unstructured":"Ohta T, Sakano T, Igarashi T, Itami N, Ogawa T, ARF Assocoated with Renal Hypouricemia Research Group. Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan. Nephrol Dial Transpl. 2004, Jun;19(6):1447\u201353. https:\/\/doi.org\/10.1093\/ndt\/gfh094. PMID: 15150354.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"4626_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1464-410x.1979.tb02838","volume":"51","author":"M Frank","year":"1979","unstructured":"Frank M, Many M, Sperling O. Familial renal hypouricaemia: two additional cases with uric acid lithiasis. Br J Urol. 1979, Apr;51(2):88\u201391. https:\/\/doi.org\/10.1111\/j.1464-410x.1979.tb02838. x. PMID: 465979.","journal-title":"Br J Urol"},{"key":"4626_CR43","doi-asserted-by":"publisher","unstructured":"Sasaki M, Takenawa J, Kanamaru H. A case of idiopathic hypouricemia due to augmented renal tubular secretion of uric acid. Nihon Hinyokika Gakkai Zasshi. 1986, Aug;77(8):1349\u201352. Japanese. doi: https:\/\/doi.org\/10.5980\/jpnjurol1928.77.8_1349. PMID: 3795681.","DOI":"10.5980\/jpnjurol1928.77.8_1349"},{"issue":"1","key":"4626_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12882-023-03378-w","volume":"24","author":"J Zhou","year":"2023","unstructured":"Zhou J, Zhang M, Xie Q, Xu N, Li M, Zhang M, Hao C. Recurrent exercise-induced acute kidney injury associated with hypouricemia: a case report and literature review. BMC Nephrol. 2023, Dec, 21;24(1):384. https:\/\/doi.org\/10.1186\/s12882-023-03378-w. PMID: 38129773; PMCID: PMC10740252.","journal-title":"BMC Nephrol"},{"issue":"6","key":"4626_CR45","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3904\/kjim.2020.410","volume":"35","author":"JH Park","year":"2020","unstructured":"Park JH, Jo YI, Lee JH. Renal effects of uric acid: hyperuricemia and hypouricemia. The Korean J Intern Med. 2020, Nov;35(6):1291\u2013304. https:\/\/doi.org\/10.3904\/kjim.2020.410. Epub 2020 Sep 9. PMID: 32872730; PMCID: PMC7652664.","journal-title":"The Korean J Intern Med"},{"key":"4626_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cca.2021.09.002","volume":"523","author":"W Sun","year":"2021","unstructured":"Sun W, Yang J, Zhang Y, Zhang W, Song X, Fan Y, Zhou X. Identification of two novel heterozygous SLC2A9 mutations in a Chinese woman and review of literature. Clin Chim Acta. 2021, Dec;523:58\u201364. https:\/\/doi.org\/10.1016\/j.cca.2021.09.002. Epub 2021 Sep 6. PMID: 34499869.","journal-title":"Clin Chim Acta"},{"key":"4626_CR47","doi-asserted-by":"publisher","first-page":"1420998","DOI":"10.3389\/fendo.2024.1420998","volume":"15","author":"K Sun","year":"2025","unstructured":"Sun K, Wang X, Chen D, Ma C. Correlation analysis of Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience. Front Endocrinol (lausanne). 2025 Feb, 6;15:1420998. https:\/\/doi.org\/10.3389\/fendo.2024.1420998. PMID: 39981137; PMCID: PMC11840962.","journal-title":"Front Endocrinol (lausanne)"},{"key":"4626_CR48","doi-asserted-by":"publisher","first-page":"1514857","DOI":"10.3389\/fendo.2025.1514857","volume":"16","author":"M Yan","year":"2025","unstructured":"Yan M, Shi W, Gong P, Xie Y, Zhang K, Li X, Wei H. A U-shaped non-linear association between serum uric acid levels and the risk of Hashimoto\u2019s thyroiditis: a cross-sectional study. Front Endocrinol (lausanne). 2025, Feb, 4;16:1514857. https:\/\/doi.org\/10.3389\/fendo.2025.1514857. PMID: 39980855; PMCID: PMC11841392.","journal-title":"Front Endocrinol (lausanne)"},{"issue":"10","key":"4626_CR49","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, Angeletti D, Fiore M, D\u2019Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A. Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020, Oct;19(10):102649. https:\/\/doi.org\/10.1016\/j.autrev.2020.102649. Epub 2020 Aug 15. PMID: 32805423.","journal-title":"Autoimmun Rev"},{"issue":"4\u20135","key":"4626_CR50","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014, Apr-May;13(4\u20135):391\u201397. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.007. Epub 2014 Jan 13. PMID: 24434360.","journal-title":"Autoimmun Rev"},{"key":"4626_CR51","doi-asserted-by":"publisher","first-page":"1452371","DOI":"10.3389\/fnut.2024.1452371","volume":"11","author":"M Yan","year":"2024","unstructured":"Yan M, Wu H, Zhang K, Gong P, Wang Y, Wei H. Analysis of the correlation between Hashimoto\u2019s thyroiditis and food intolerance. Front Nutr. 2024, Sep, 30;11:1452371. https:\/\/doi.org\/10.3389\/fnut.2024.1452371. PMID: 39403393; PMCID: PMC11471614.","journal-title":"Front Nutr"},{"issue":"1","key":"4626_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13256-022-03523-3","volume":"16","author":"M Xenou","year":"2022","unstructured":"Xenou M, Zoupas I, Lygnos D, Fousteris E. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto\u2019s thyroiditis: a case report. J Med Case Rep. 2022, Aug, 3;16(1):297. https:\/\/doi.org\/10.1186\/s13256-022-03523-3. PMID: 35918735; PMCID: PMC9347147.","journal-title":"J Med Case Rep"},{"issue":"3","key":"4626_CR53","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12020-015-0662-2","volume":"51","author":"A Rodr\u00edguez-Mu\u00f1oz","year":"2016","unstructured":"Rodr\u00edguez-Mu\u00f1oz A, Vitales-Noyola M, Ramos-Levi A, Serrano-Somavilla A, Gonz\u00e1lez-Amaro R, Marazuela M. Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders. Endocrine. 2016, Mar;51(3):478\u201389. https:\/\/doi.org\/10.1007\/s12020-015-0662-2. Epub 2015 Jun 23. PMID: 26100786.","journal-title":"Endocrine"},{"key":"4626_CR54","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2147\/DMSO.S295847","volume":"14","author":"S Wen","year":"2021","unstructured":"Wen S, Jiang W, Zhou L. Islet autoantibodies in the patients with Sjogren\u2019s syndrome and thyroid disease and risk of progression to latent autoimmune diabetes in adults: a case series. Diabetes Metab Syndr Obes. 2021, Mar, 5;14:1025\u201333. https:\/\/doi.org\/10.2147\/DMSO.S295847. PMID: 33707961; PMCID: PMC7943329.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4626_CR55","doi-asserted-by":"publisher","unstructured":"Yetkin DO, Dogantekin B. The lipid parameters and Lipoprotein(a) excess in Hashimoto Thyroiditis. Int J Endocrinol. 2015; 2015;952729. https:\/\/doi.org\/10.1155\/2015\/952729. Epub 2015 May 3. PMID: 26064115; PMCID: PMC4433708.","DOI":"10.1155\/2015\/952729"},{"key":"4626_CR56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fendo.2018.00130","volume":"9","author":"J Liu","year":"2018","unstructured":"Liu J, Duan Y, Fu J, Wang G. Association between thyroid hormones, thyroid antibodies, and cardiometabolic factors in non-obese individuals with normal thyroid function. Front Endocrinol (lausanne). 2018, Apr, 5;9:130. https:\/\/doi.org\/10.3389\/fendo.2018.00130. PMID: 29674996; PMCID: PMC5895644.","journal-title":"Front Endocrinol (lausanne)"},{"issue":"8","key":"4626_CR57","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4158\/EP-2020-0008","volume":"26","author":"Y Wu","year":"2020","unstructured":"Wu Y, Shi X, Tang X, Li Y, Tong N, Wang G, Zhang JA, Wang Y, Ba J, Chen B, Du J, He L, Lai X, Li Y, Chi H, Liao E, Liu C, Liu L, Qin G, Qin Y, Quan H, Shi B, Sun H, Xue Y, Yan L, Yang J, Yang L, Yao Y, Ye Z, Zhang Q, Zhang L, Zhu J, Zhu M, Teng W, Shan Z. The correlation between metabolic disorders and Tpoab\/Tgab: a cross-sectional population-based study. Endocr Pract. 2020, Aug;26(8):869\u201382. https:\/\/doi.org\/10.4158\/EP-2020-0008. PMID: 33471678.","journal-title":"Endocr Pract"},{"issue":"5","key":"4626_CR58","first-page":"421","volume":"62","author":"G Tamer","year":"2011","unstructured":"Tamer G, Mert M, Tamer I, Mesci B, Kilic D, Arik S. Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol Pol. 2011;62(5):421\u201328. PMID: 22069103.","journal-title":"Endokrynol Pol"},{"key":"4626_CR59","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2147\/DMSO.S345507","volume":"15","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zheng J, Ye X, Song Y, Wu X. Association between elevated thyroid peroxidase antibody and abdominal fat distribution in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2022, Mar, 17;15:863\u201371. https:\/\/doi.org\/10.2147\/DMSO.S345507. PMID: 35321353; PMCID: PMC8938158.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4626_CR60","doi-asserted-by":"publisher","unstructured":"The genome sequence archive family: toward explosive data growth and diverse data types. Genomics, Proteomics Bioinf. 2021;19(4):578\u201383. https:\/\/doi.org\/10.1016\/j.gpb.2021.08.001. PMID=34400360.","DOI":"10.1016\/j.gpb.2021.08.001"},{"issue":"D1","key":"4626_CR61","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"Database Resources of the National Genomics Data Center","year":"2022","unstructured":"Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2022. Nucleic Acids Res. 2022;50(D1):D27\u201338. https:\/\/doi.org\/10.1093\/nar\/gkab951. PMID=34718731.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04626-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:02:20Z","timestamp":1767708140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04626-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4626"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04626-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required for this case report. Written informed consent was obtained from the patient prior to her inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}